Up until yesterday it seemed every purchase and se

Up until yesterday it seemed every purchase and sell order can be identified. With the increased awareness and visibility SCRC is gaining each day we will hit a stride where orders will be coming in from everywhere. It has been a long time coming but through the genius of Mr. Schneiderman's perfect timing of his awareness campaign with the SeeThruEquity conference and conference call, along with continue monthly revenue growth, SCRC will be considered one of the top penny stocks recommended to buy. Over 3000 views on the Hangout yesterday. There is no way that was the CORE checking in, it was new investors checking SCRC out. Believe me, I'm no expert, but I see short and long term buyers over the next weeks and months which will create a pps growth curve that will fluctuate but demonstrate a steady climb north.

Yesterday's performance breaking .18 with over 2M shares traded was exciting. There shouldn't be any surprise here. This is exactly what Celtics called for. Will it continue? This is the stock market, who knows. All I know is Mr. Schneiderman ends every PR with some sort of phrase relating to, "best for the shareholder", and his efforts are bringing this statement to life. In 2015 SCRC will be the stock which will satisfy everyone's short or long term investment goal.

Are you concerned about the compounding business? You shouldn't be. Even if there are price controls implemented the compounding pharmacy market will continue to grow. Tut posted an article stating compounding will be a $6B market. Look at the Pfizers, GSKs, and Mercks out there. They constantly deal with regulations and price controls but continue to yield billions in revenues. Compounding is a multi-billion dollar market which is created and influenced more by the physicians demand for the product than by third party payers. As long as we have 1099 Reps out there I can assure the demand will continue to flourish.

I know I've gone on and on here, but I need to say for anyone concerned about SCRC being a one product or one service company, don't. Mr Schneiderman, SCRC's CEO has never given up on RapiMeds and he won't. The real potential for this product is incredible. Its taking longer than expected to be launch in the Asian market, but it will be because SCRC's CEO says it will. He also stated in an interview late last year that he believes RapiMeds will mirror compounding's success. With the success of SCRC over the last nine months why would anyone doubt him?